Patent Application
Utility
App. No. 16/407,458
· Confirmation No. 1062
USE OF AMINOSALICYLATES IN DIARRHOEA-PREDOMINENT IRRITABLE BOWEL SYNDROME
Inventor:
Nicolas Peter Shortis
Applicant:
Salix Pharmaceuticals, Inc.
Abandoned -- Failure to Respond to an Office Action
View Publication ↗
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2020-11-03 | ABN |
Abandonment | 2 | View | |
| 2020-04-13 | CTNF |
Non-Final Rejection | 7 | View | |
| 2020-04-13 | SRFW |
Search information including classification, databases and other search related notes | 1 | View | |
| 2020-04-13 | SRNT |
Examiner's search strategy and results | 3 | View | |
| 2020-04-13 | BIB |
Bibliographic Data Sheet | 1 | View | |
| 2020-04-13 | 1449 |
List of References cited by applicant and considered by examiner | 6 | View | |
| 2020-04-13 | SRNT |
Examiner's search strategy and results | 2 | View | |
| 2020-04-13 | 1449 |
List of References cited by applicant and considered by examiner | 15 | View | |
| 2020-04-02 | NTC.PUB |
Notice of Publication | 1 | View | |
| 2020-01-24 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 6 | View | |
| 2020-01-24 | TRAN.LET |
Transmittal Letter | 2 | View | |
| 2020-01-24 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2020-01-24 | IDS |
Information Disclosure Statement (IDS) Form (SB08) | 15 | View | |
| 2019-12-23 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-12-23 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-12-19 | PEFR |
Applicant Response to Pre-Exam Formalities Notice | 1 | View | |
| 2019-12-19 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2019-12-19 | N417 |
Electronic Filing System Acknowledgment Receipt | 2 | View | |
| 2019-12-19 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-12-19 | CLM |
Claims | 3 | View | |
| 2019-12-19 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View | |
| 2019-05-21 | WFEE |
Fee Worksheet (SB06) | 1 | View | |
| 2019-05-21 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2019-05-21 | NTC.MISS.PRT |
Notice to File Missing Parts | 2 | View | |
| 2019-05-09 | TRNA |
Transmittal of New Application | 1 | View | |
| 2019-05-09 | OATH |
Oath or Declaration filed | 1 | View | |
| 2019-05-09 | ADS |
Application Data Sheet | 9 | View | |
| 2019-05-09 | PA.. |
Power of Attorney | 1 | View | |
| 2019-05-09 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View | |
| 2019-05-09 | ABST |
Abstract | 1 | View | |
| 2019-05-09 | SPEC |
Specification | 12 | View | |
| 2019-05-09 | CLM |
Claims | 2 | View | |
| 2019-05-09 | A.PE |
Preliminary Amendment | 1 | View | |
| 2019-05-09 | SPEC |
Specification | 1 | View | |
| 2019-05-09 | REM |
Applicant Arguments/Remarks Made in an Amendment | 1 | View |
Inventors
Nicolas Peter Shortis
Pymble, AUSTRALIA
Attorneys & Agents of Record
Classification
USPC
514/166
A61K31/655
A61K31/166
A61K31/437
A61K31/606
A61K31/635
A61K45/06
A61K2300/00
Prosecution
- Examiner
- ANDERSON, JAMES D
- Art Unit
- 1629
- Customer No.
- 75093
- Docket No.
- 119557-04605
- Confirmation No.
- 1062
Foreign Priority
2004900563
·
2004-02-06
·
AUSTRALIA
Publication
- Pub. No.
- US20200101090A1
- Pub. Date
- 2020-04-02
Parent
is a Continuation of
→
App. 15/907,566
· US 10,328,088
Filed 2018-02-28
· Patented Case
Parent
is a Continuation of
→
App. 14/585,911
· US 9,937,190
Filed 2014-12-30
· Patent Expired Due to NonPayment of Maintenance Fees Under 37 CFR 1.362
Parent
is a Continuation of
→
App. 13/742,837
Filed 2013-01-16
· Abandoned -- Failure to Respond to an Office Action
Parent
is a Continuation of
→
App. 10/588,558
Filed 2007-05-25
· Abandoned -- Failure to Respond to an Office Action
Parent
PCT
is a National Stage Entry of
→
PCT/AU2005/000142
Filed 2005-02-04
· Abandoned -- Failure to Respond to an Office Action
SOLTA MEDICAL, INC.,
PRECISION DERMATOLOGY, INC.,
BAUSCH HEALTH IRELAND LIMITED (F/K/A/ VALEANT PHARMACEUTICALS IRELAND LIMITED),
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SANTARUS, INC.,
MEDICIS PHARMACEUTICAL CORPORATION,
HUMAX PHARMACEUTICAL S.A.,
SOLTA MEDICAL IRELAND LIMITED,
BAUSCH & LOMB MEXICO, S.A. DE C.V.,
BAUSCH+LOMB OPS B.V.,
BAUSCH HEALTH AMERICAS, INC.,
BAUSCH HEALTH COMPANIES INC.,
BAUSCH HEALTH HOLDCO LIMITED,
BAUSCH HEALTH MAGYARORSZAG KFT (A/K/A BAUSCH HEALTH HUNGARY LLC),
BAUSCH HEALTH POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA (F/K/A VALEANT PHARMA POLAND SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA),
BAUSCH HEALTH US, LLC,
BAUSCH HEALTH, CANADA INC. / SANTE BAUSCH, CANADA INC.,
ICN POLFA RZESZOW SPOLKA AKCYJNA (A/K/A ICN POLFA RZESZOW S.A.),
ORAPHARMA, INC.,
PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA SPOLKA AKCYJNA (A/K/A PRZEDSIEBIORSTWO FARMACEUTYCZNE JELFA S.A.),
SOLTA MEDICAL DUTCH HOLDINGS B.V.,
V-BAC HOLDING CORP.,
VRX HOLDCO LLC,
1261229 B.C. LTD.,
1530065 B.C. LTD.
RELEASE OF SECURITY INTEREST
Recorded 2025-04-08
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2020-05-06
from
BAUSCH & LOMB INCORPORATED,
BAUSCH HEALTH IRELAND LIMITED,
SALIX PHARMACEUTICALS, INC.,
SALIX PHARMACEUTICALS, LTD,
SOLTA MEDICAL, INC.
SECURITY INTEREST
Recorded 2020-05-06
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded 2019-06-07
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 16/407,458
- Filed
- 2019-05-09
- Pub. No.
- US20200101090A1
- Examiner
- ANDERSON, JAMES D
- Art Unit
- 1629
External Links